Combinations of recently developed paradoxical concanavalin-A staining (PCS) and other routine histochemical procedures have made it possible to classify mucosubstances more precisely. By taking advantage of these sequences, the present study was undertaken both to characterize the mucinous contents of alimentary tracts of several animal species, and to compare the variability of epithelial mucosubstances with special reference to the mucous neck cells of the stomach. The alimentary tracts obtained from 7 species of fish, 5 amphibians, 3 reptiles, 4 birds, and 6 mammals were used. Acidity of epithelial mucosubstances was highly variable even among the corresponding mucous cells. On the contrary, concanavalin-A reactivity seemed to be consistent with each cell and species. The mucous neck cells, which were observed in amphibians, reptiles, and mammals, consistently exhibited a characteristic mucosubstance with stable class-III reactivity by PCS. Inversely, stable class-III reactivity was found only in species possessing mucous neck cells, and was widely distributed in the esophageal glands of the frog, snake, and man; in esophageal mucous cells of the frog and skink; in pyloric glands of amphibia, reptiles, and mammals; and in Brunner's glands of mammals. These mucous cells seem to form an unique group with morphological and histochemical similarities. It is likely that the stable class-III reactivity by PCS is a hallmark of the mucous neck cells and related glands and that, in addition, concanavalin-A reactivity of mucosubstances is evolutionarily more fundamental characteristic.
Principles and methods for scanning electrode quartz crystal analysis (SEQCA) as a technique for mapping distribution of mass and measuring interfacial rheology are described. In SEQCA, quartz crystal resonates in a region between a normal electrode and a microelectrode scanned over the opposite side of the normal electrode. The surface of the quartz crystal plate just below the scanning electrode is monitored (overscanning mode). A prototype system for the scanning electrode quartz crystal analysis is constructed. The dependence of the resonance properties on the location of the scanning electrode is studied. As a result, it was found that the qualitative mapping of the mass distribution is possible in the lateral resolution of 1 (9 MHz quartz) to 2 (5 MHz) mm. Viscoelastic properties of the load on the quartz surface are also measured qualitatively.
Objective Laboratory-based polysomnography (PSG) is the gold standard for diagnosing obstructive sleep apnea-hypopnea syndrome (OSAHS), but it is expensive and requires overnight hospitalization. Recently, a sheet-shaped breath detection monitor, the SD-101, has been developed, and several reports have so far demonstrated the screening accuracy of this device. The aim of this study was to assess the accuracy and the uncertainty of this device. Methods A total of 101 suspected OSAHS patients underwent simultaneous examinations with PSG and the SD-101. Results There was a statistically significant relationship between the respiratory disturbance index (RDI) by the SD-101 and the apnea-hypopnea index (AHI) by PSG. At an RDI cutoff of 14 episodes per hour, the sensitivity and specificity to detect an AHI ! 20 episodes per hour were 90.2% and 90.0%, respectively. To reduce the influence of sleep efficiency, the time in bed (TIB) obtained from PSG, instead of the total seep time (TST), was used to calculate the AHI from the PSG data. There was also a statistically significant relationship between the RDI and AHI for the TIB. Moreover, it was suggested that arousal index and TIB were likely associated with false-negative and/or false-positive results.Conclusion Although the present study demonstrated a close relationship between the RDI and the AHI, use of the SD-101 to examine symptomatic OSAHS patients should be performed with a full understanding of its incapability to detect the sleep state, including arousal reaction and the existence of false respiratory events caused by body movements.
Sarcoma-like cells (SCLs) were derived from endarterectomized tissue of a single chronic thromboembolic pulmonary hypertension (CTEPH) patient during incubation of those thrombi at second passage as described at our previous report. These cells had malignant potential, with an increased expression of matrix metalloproteinase-14 (MMP-14), leading to tumor emboli within pulmonary arteries in in vivo studies. The purpose of this study was to perform a more detailed evaluation of the characteristics of SCLs, and to elucidate the role of the increased expression of MMP-14 expression in the growth and death of these cells. In order to elucidate the characteristics of SCLs and to confirm the protein expression of MMP-14, three-dimentional culture, invasion assays, a Western blot analysis and immunohistochemical studies were performed. To examine the role of MMP-14 in tumorigenesis, the metalloproteinase inhibitor, batimastat, was administered to SCID mice which were subcutaneously injected with SCLs. Those mice were sacrificed on day 14 and the tumor volume was evaluated. A Western blot analysis showed the increased expression of MMP-14 in comparison to the expression in lung adenocarcinoma cells (A549). Immunohistochemistry showed that SCLs were positive for vimentin, MMP-14, MMP-2 and CD44. However, endothelial markers, such as CD31 and von Willebrand factor (vWF), were negative. The in vivo studies demonstrated that batimastat could suppress the growth of the subcutaneous tumors formed by the SCLs. This study suggested that MMPs had critical roles on the pathological activities of SCLs and that batimastat might have anti-proliferative and anti-invasive effects on these cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.